Acquired thrombophilias;Trombofilias adquiridas

Medicina

Volumn 34, Issue 3-4, 2001, Pages 258-268

  Garcia, Andrea A ^a,b   Franco, Rendrik F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FUNDHERP   (Brazil)

Author keywords

Risk Factors; Thrombosis

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; BLOOD VISCOSITY; CLINICAL FEATURE; CONFERENCE PAPER; HEMOSTASIS; HUMAN; MYELOPROLIFERATIVE DISORDER; NEPHROTIC SYNDROME; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PUERPERIUM; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 1842429896     PISSN: 00766046     EISSN: None     Source Type: Journal    
DOI: 10.11606/issn.2176-7262.v34i3/4p258-268     Document Type: Conference Paper

References (26)

1. HIRSH J; KEARON C & GINSBERG J. Duration of anticoagulant therapy after first episode of venous thrombosis in patents with inherited thrombophilia. Arch Int Med 157: 2174-2177, 1997.
2. ROSENDAAL FR. Venous thrombosis: a multicausal disease. Lancet 353: 1167-1173, 1999.
3. ZOLLER B; GARCIA DE FRUTOS P; HILLARP A & DAHLBACK B. Trombophilia as a multigenic disease. Haematologica 84: 59-70, 1999.
4. nd ed,. Williams & Wilkins, p.881-890, 1998.
5. th ed,. Lippincott, Williams & Wilkins, p. 1242-1257, 2001.
6. GREAVES M. Antiphospholipid antibodies and thrombosis. Lancet 353: 1348-1353, 1999.
7. PIERANGELI SS; GHARAVI AE & NIGEL HARRIS E. Experimental thrombosis and antiphospholipid antibodies: new insights. J Autoimmun 15: 241-247, 2000.
8. RAI R; COHEN H; DAVE M & REGAN L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant womem with recurrent miscarriage associated with phospholipid antibodies. Br Med J 314: 253-257, 1997.
9. RAI R. Obstetric management of antiphospholipid syndrome. J Autoimmun 15: 203-207, 2000.
10. DERKSEN RHWM & DE GROOT PG. Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation? J Autoimmun 15: 255-259, 2000.
11. WILSON WA; GHARAVI AE; KOIKE T; LOCKSHIN MD; BRANCH DW; PIETTE JC; BREY R; DERKSEN R; HARRIS EN; HUGHES GRV; TRIPLETT DA & KHAMASHTA MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42: 1309-1311, 1999.
12. NIGEL HE & PIERANGELL SS. Equivocal antiphospholipid syndrome. J Autoimmun 15: 81-85, 2000.
13. DIUGUID DL. Oral anticoagulant therapy for venous thromboembolism. N Engl J Med 336: 433-434, 1997.
14. KHAMASHTA MA. Primary prevention of trombosis in subjects with positive antiphospholid antibodies. J Autoimmun 15: 249-253, 2000.
15. KUTTEH WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174: 1584-1589, 1996
16. LOCKSHIN MD. Future trends for APS. J Autoimmun 15: 261-264, 2000.
17. KHAMASHTAMA; CUADRADO MJ; MUJIC F; TAUB NA; HUNT BJ & HUGHES RV. A management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332: 993-997, 1995.
18. FISHMAN P; FALACH VE; SREDNI B; MERONI PL; RUDNIKI C & SHOENFELD Y. Aspirin modulates interleukin-3 production: additional explanation for the preventive effects of aspirin in antiphospholipid antibody syndrome. J Rheumatol 22: 1086-1090, 1995.
19. th ed. McGrawHill, New York, p.419-424, 2001.
20. LUZZATTO L. New insights into the pathophysiology of acquired cytopenias. III. Paroxysmal nocturnal hemoglobinuria. In: AMERICAN SOCIETY of HEMATOLOGY. Education Program Book. San Francisco, p.18-38, 2000.
21. HALL SE & ROSSE WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 87: 5332-5340, 1996.
22. HILLMEN P. Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria. Br J Haematol 108: 470-479, 2000.
23. HUGEL B; SOCIÉ G; TOTI F; VU T; GLUCKMAN E.; FREYSSINET JM & SCROBOHACI ML. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 93: 3451-3456, 1999.
24. ROSTI V. The molecular basis of paroxysmal nocturnal hemoglobinuria Haematologica 85: 82-87, 2000.
25. TREMML G; KARADIMITRIS A & LUZZATO L. Paroxysmal nocturnal hemoglobinuria: learning about PNH cells from patients and from mice. Haematology 1: 12-20, 1998.
26. BUCALOSSI A; MAROTTA G; BIGAZZI C; GALIENI P & DISPENSA E. Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in policythemia vera and essential thrombocythemia patients with thrombosis. Am J Hematol 52: 14-20, 1996.